[Pharm-policy] Note on d4T

[James Love]

Subject:  [Ip-health] correction on d4t
   Date:  Mon, 07 Feb 2000 10:56:17 -0500
      From: Thiru Balasubramaniam <thiru@cptech.org>

Stavudine (d4t) was originally synthesized by Dr. Jerome Horowitz of the
Michigan Cancer Foundation in 1966 on a grant from the National Cancer
Institute.  Dr. William Prusoff of Yale University first discovered
d4T's capability to treat HIV/AIDS. Yale University holds the key use
patent.  Yale licensed d4T to Bristol-Myers Squibb for marketing and
distribution on January 12, 1988. Yale used significant government
funding under Grant CA-28852 from the NIH.

Thiru